en
Scientific article
English

Data quality in rare cancers registration: the report of the RARECARE data quality study

Published inTumori, vol. 103, no. 1, p. 22-32
Publication date2017
Abstract

Rare cancers represent 22% of all tumors in Europe; however, the quality of the data of rare cancers may not be as good as the quality of data for common cancer. The project surveillance of rare cancers in Europe (RARECARE) had, among others, the objective of assessing rare cancer data quality in population-based cancer registries (CRs). Eight rare cancers were considered: mesothelioma, liver angiosarcoma, sarcomas, tumors of oral cavity, CNS tumors, germ cell tumors, leukemia, and malignant digestive endocrine tumors.

Citation (ISO format)
TRAMA, Annalisa et al. Data quality in rare cancers registration: the report of the RARECARE data quality study. In: Tumori, 2017, vol. 103, n° 1, p. 22–32. doi: 10.5301/tj.5000559
Identifiers
ISSN of the journal0300-8916
487views
0downloads

Technical informations

Creation11/14/2016 4:52:00 PM
First validation11/14/2016 4:52:00 PM
Update time03/15/2023 12:57:36 AM
Status update03/15/2023 12:57:36 AM
Last indexation01/16/2024 10:19:26 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack